Do you offer consolidative thoracic radiation for oligometastatic NSCLC following upfront immunotherapy?  

In patients who have a mixed response or progression and are poor candidates for other systemic agents, would you consider consolidating the chest? Would you be concerned about a higher pneumonitis risk?

Answer from: Radiation Oncologist at Community Practice

Answer from: Radiation Oncologist at Academic Institution
Radiation Oncologist at Wake Forest School of Medicine
What do you include in your treatment volumes afte...
Sign in or Register to read more